{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:13:39Z","timestamp":1791980019429,"version":"4.4.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Alma Mater Studiorum - Universit\u00e0 di Bologna"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s40256-024-00676-y","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T11:06:17Z","timestamp":1725620777000},"page":"813-821","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Impact of Newly Diagnosed Cancer on Bleeding Events in Patients with Atrial Fibrillation Treated with Direct Oral Anticoagulants"],"prefix":"10.1007","volume":"24","author":[{"given":"Francesco","family":"Angeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Bergamaschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Armillotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Sansonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Stefanizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Canton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Bodega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Suma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Amicone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damiano","family":"Fedele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Bertolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Impellizzeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Pio","family":"Tattilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Cavallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Bartoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ornella","family":"Di Iuorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khrystyna","family":"Ryabenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Casuso Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Marinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Asta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariachiara","family":"Ciarlantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Pastore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Paola","family":"Pomata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Caldarera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4048-675X","authenticated-orcid":false,"given":"Carmine","family":"Pizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,6]]},"reference":[{"key":"676_CR1","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ijcard.2016.06.009","volume":"219","author":"W-L Cheng","year":"2016","unstructured":"Cheng W-L, Kao Y-H, Chen S-A, Chen Y-J. Pathophysiology of cancer therapy-provoked atrial fibrillation. Int J Cardiol. 2016;219:186\u201394.","journal-title":"Int J Cardiol"},{"key":"676_CR2","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.amjcard.2015.01.540","volume":"115","author":"WT O\u2019Neal","year":"2015","unstructured":"O\u2019Neal WT, Lakoski SG, Qureshi W, et al. Relation between cancer and atrial fibrillation (from the reasons for geographic and racial differences in stroke study). Am J Cardiol. 2015;115:1090\u20134.","journal-title":"Am J Cardiol"},{"key":"676_CR3","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jacc.2013.11.026","volume":"63","author":"D Farmakis","year":"2014","unstructured":"Farmakis D, Parissis J, Filippatos G. Insights into onco-cardiology. J Am Coll Cardiol. 2014;63:945\u201353.","journal-title":"J Am Coll Cardiol"},{"key":"676_CR4","doi-asserted-by":"crossref","unstructured":"Guzzetti S, Costantino G, Fundar\u00f2 C. Systemic inflammation, atrial fibrillation, and cancer. Circulation. 2002;106(9):e40.","DOI":"10.1161\/01.CIR.0000028399.42411.13"},{"key":"676_CR5","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.jaccao.2020.11.002","volume":"2","author":"AM Russo","year":"2020","unstructured":"Russo AM. Anticoagulation in cancer patients with atrial fibrillation or atrial flutter. JACC CardioOncol. 2020;2:755\u20137.","journal-title":"JACC CardioOncol."},{"key":"676_CR6","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/bjc.2011.338","volume":"105","author":"R Erichsen","year":"2011","unstructured":"Erichsen R, Christiansen CF, Fr\u00f8slev T, Jacobsen J, S\u00f8rensen HT. Intravenous bisphosphonate therapy and atrial fibrillation\/flutter risk in cancer patients: a nationwide cohort study. Br J Cancer. 2011;105:881\u20133.","journal-title":"Br J Cancer"},{"key":"676_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/20009666.2020.1726571","volume":"10","author":"N Lateef","year":"2020","unstructured":"Lateef N, Kapoor V, Ahsan MJ, et al. Atrial fibrillation and cancer; understanding the mysterious relationship through a systematic review. J Community Hosp Intern Med Perspect. 2020;10:127\u201332.","journal-title":"J Community Hosp Intern Med Perspect."},{"key":"676_CR8","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1093\/eurjpc\/zwab032","volume":"29","author":"A Fo\u00e0","year":"2022","unstructured":"Fo\u00e0 A, Paolisso P, Bergamaschi L, et al. Clues and pitfalls in the diagnostic approach to cardiac masses: are pseudo-tumours truly benign? Eur J Prev Cardiol. 2022;29:e102\u20134.","journal-title":"Eur J Prev Cardiol"},{"key":"676_CR9","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.3390\/jcm12082958","volume":"12","author":"F Angeli","year":"2023","unstructured":"Angeli F, Bergamaschi L, Rinaldi A, et al. Sex-related disparities in cardiac masses: clinical features and outcomes. J Clin Med. 2023;12:2958.","journal-title":"J Clin Med"},{"key":"676_CR10","first-page":"620","volume":"23","author":"F Angeli","year":"2022","unstructured":"Angeli F, Fabrizio M, Paolisso P, et al. Cardiac masses: classification, clinical features and diagnostic approach [in Italian]. G Ital Cardiol (Rome). 2022;23:620\u201330.","journal-title":"G Ital Cardiol (Rome)."},{"issue":"11","key":"676_CR11","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/j.jcmg.2022.06.005","volume":"15","author":"P Paolisso","year":"2022","unstructured":"Paolisso P, Fo\u00e0 A, Magnani I, et al. Development and validation of a diagnostic echocardiographic mass score in the approach to cardiac masses. JACC Cardiovasc Imaging. 2022;15(11):2010\u20132.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"676_CR12","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.echo.2022.12.022","volume":"36","author":"P Paolisso","year":"2023","unstructured":"Paolisso P, Fo\u00e0 A, Bergamaschi L, et al. Echocardiographic markers in the diagnosis of cardiac masses. J Am Soc Echocardiogr. 2023;36(5):464-473.e2.","journal-title":"J Am Soc Echocardiogr"},{"key":"676_CR13","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1016\/j.jcmg.2020.03.021","volume":"13","author":"EC D\u2019Angelo","year":"2020","unstructured":"D\u2019Angelo EC, Paolisso P, Vitale G, et al. Diagnostic accuracy of cardiac computed tomography and 18-F fluorodeoxyglucose positron emission tomography in cardiac masses. JACC Cardiovasc Imaging. 2020;13:2400\u201311.","journal-title":"JACC Cardiovasc Imaging"},{"key":"676_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1476-7120-6-21","volume":"6","author":"G Bedetti","year":"2008","unstructured":"Bedetti G, Pasanisi EM, Pizzi C, Turchetti G, Lor\u00e9 C. Economic analysis including long-term risks and costs of alternative diagnostic strategies to evaluate patients with chest pain. Cardiovasc Ultrasound. 2008;6:21.","journal-title":"Cardiovasc Ultrasound"},{"key":"676_CR15","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jacr.2007.07.020","volume":"5","author":"G Bedetti","year":"2008","unstructured":"Bedetti G, Pizzi C, Gavaruzzi G, Lugaresi F, Cicognani A, Picano E. Suboptimal awareness of radiologic dose among patients undergoing cardiac stress scintigraphy. J Am Coll Radiol. 2008;5:126\u201331.","journal-title":"J Am Coll Radiol"},{"key":"676_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.590768","volume":"8","author":"LA Hajjar","year":"2021","unstructured":"Hajjar LA, Fonseca SMR, Machado TIV. Atrial fibrillation and cancer. Front Cardiovasc Med. 2021;8: 590768.","journal-title":"Front Cardiovasc Med."},{"key":"676_CR17","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"AR Lyon","year":"2022","unstructured":"Lyon AR, L\u00f3pez-Fern\u00e1ndez T, Couch LS, et al. 2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J. 2022;43:4229\u2013361.","journal-title":"Eur Heart J"},{"key":"676_CR18","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","volume":"37","author":"JL Zamorano","year":"2016","unstructured":"Zamorano JL, Lancellotti P, Rodriguez Mu\u00f1oz D, et al. 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for practice guidelines: the task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J. 2016;37:2768\u2013801.","journal-title":"Eur Heart J"},{"key":"676_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.thromres.2017.05.006","volume":"155","author":"T Fitzpatrick","year":"2017","unstructured":"Fitzpatrick T, Carrier M, Le Gal G. Cancer, atrial fibrillation, and stroke. Thromb Res. 2017;155:101\u20135.","journal-title":"Thromb Res"},{"key":"676_CR20","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1055\/s-0037-1607436","volume":"44","author":"V Russo","year":"2018","unstructured":"Russo V, Rago A, Papa A, et al. Use of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with malignancy: clinical practice experience in a single institution and literature review. Semin Thromb Hemost. 2018;44:370\u20136.","journal-title":"Semin Thromb Hemost"},{"key":"676_CR21","first-page":"1612","volume":"23","author":"J Steffel","year":"2021","unstructured":"Steffel J, Collins R, Antz M, et al. 2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. EP Eur. 2021;23:1612\u201376.","journal-title":"EP Eur."},{"key":"676_CR22","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2021;42:373\u2013498.","journal-title":"Eur Heart J"},{"key":"676_CR23","doi-asserted-by":"crossref","unstructured":"Anon. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(2):2191\u20134.","DOI":"10.1001\/jama.2013.281053"},{"key":"676_CR24","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1017\/S1368980008002401","volume":"12","author":"E McLean","year":"2009","unstructured":"McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B. Worldwide prevalence of anaemia, WHO vitamin and mineral nutrition information system, 1993\u20132005. Public Health Nutr. 2009;12:444.","journal-title":"Public Health Nutr"},{"key":"676_CR25","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1016\/S2352-3026(14)70018-3","volume":"1","author":"MH Prins","year":"2014","unstructured":"Prins MH, Lensing AWA, Brighton TA, et al. Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials. Lancet Haematol. 2014;1:e37\u201346.","journal-title":"Lancet Haematol."},{"key":"676_CR26","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1111\/jth.13153","volume":"13","author":"G Agnelli","year":"2015","unstructured":"Agnelli G, Buller HR, Cohen A, et al. Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial. J Thromb Haemost. 2015;13:2187\u201391.","journal-title":"J Thromb Haemost"},{"key":"676_CR27","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1161\/STR.0b013e318296aeca","volume":"44","author":"RL Sacco","year":"2013","unstructured":"Sacco RL, Kasner SE, Broderick JP, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2013;44:2064\u201389.","journal-title":"Stroke"},{"key":"676_CR28","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","volume":"40","author":"K Thygesen","year":"2019","unstructured":"Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019;40:237\u201369.","journal-title":"Eur Heart J"},{"key":"676_CR29","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"S Schulman","year":"2005","unstructured":"Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3:692\u20134.","journal-title":"J Thromb Haemost"},{"key":"676_CR30","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nrcardio.2015.2","volume":"12","author":"Y-F Hu","year":"2015","unstructured":"Hu Y-F, Chen Y-J, Lin Y-J, Chen S-A. Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol. 2015;12:230\u201343.","journal-title":"Nat Rev Cardiol"},{"key":"676_CR31","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ijcard.2017.03.132","volume":"240","author":"B Mery","year":"2017","unstructured":"Mery B, Guichard J-B, Guy J-B, et al. Atrial fibrillation in cancer patients: hindsight, insight and foresight. Int J Cardiol. 2017;240:196\u2013202.","journal-title":"Int J Cardiol"},{"key":"676_CR32","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1177\/2047487318759858","volume":"25","author":"M D\u2019Souza","year":"2018","unstructured":"D\u2019Souza M, Carlson N, Fosb\u00f8l E, et al. CHA2 DS2-VASc score and risk of thromboembolism and bleeding in patients with atrial fibrillation and recent cancer. Eur J Prev Cardiol. 2018;25:651\u20138.","journal-title":"Eur J Prev Cardiol"},{"key":"676_CR33","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.amjcard.2017.04.009","volume":"120","author":"ES Laube","year":"2017","unstructured":"Laube ES, Yu A, Gupta D, et al. Rivaroxaban for stroke prevention in patients with nonvalvular atrial fibrillation and active cancer. Am J Cardiol. 2017;120:213\u20137.","journal-title":"Am J Cardiol"},{"key":"676_CR34","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.008987","volume":"7","author":"CL Fanola","year":"2018","unstructured":"Fanola CL, Ruff CT, Murphy SA, et al. Efficacy and safety of edoxaban in patients with active malignancy and atrial fibrillation: analysis of the ENGAGE AF-TIMI 48 trial. J Am Heart Assoc. 2018;7: e008987.","journal-title":"J Am Heart Assoc"},{"key":"676_CR35","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.amjmed.2017.06.026","volume":"130","author":"C Melloni","year":"2017","unstructured":"Melloni C, Dunning A, Granger CB, et al. Efficacy and safety of apixaban versus warfarin in patients with atrial fibrillation and a history of cancer: insights from the ARISTOTLE trial. Am J Med. 2017;130:1440-1448.e1.","journal-title":"Am J Med"},{"key":"676_CR36","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.breast.2019.05.017","volume":"46","author":"A Pardo Sanz","year":"2019","unstructured":"Pardo Sanz A, Rinc\u00f3n LM, Guedes Ramallo P, et al. Current status of anticoagulation in patients with breast cancer and atrial fibrillation. Breast. 2019;46:163\u20139.","journal-title":"Breast"},{"key":"676_CR37","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1177\/1078155217726158","volume":"25","author":"ER Pritchard","year":"2019","unstructured":"Pritchard ER, Murillo JR, Putney D, Hobaugh EC. Single-center, retrospective evaluation of safety and efficacy of direct oral anticoagulants versus low-molecular-weight heparin and vitamin K antagonist in patients with cancer. J Oncol Pharm Pract. 2019;25:52\u20139.","journal-title":"J Oncol Pharm Pract"},{"issue":"7","key":"676_CR38","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/ajh.25494","volume":"94","author":"DE Angelini","year":"2019","unstructured":"Angelini DE, Radivoyevitch T, McCrae KR, Khorana AA. Bleeding incidence and risk factors among cancer patients treated with anticoagulation. Am J Hematol. 2019;94(7):780\u20135.","journal-title":"Am J Hematol"},{"key":"676_CR39","doi-asserted-by":"publisher","first-page":"265","DOI":"10.21037\/apm.2017.11.01","volume":"7","author":"C Johnstone","year":"2018","unstructured":"Johnstone C, Rich SE. Bleeding in cancer patients and its treatment: a review. Ann Palliat Med. 2018;7:265\u201373.","journal-title":"Ann Palliat Med."},{"key":"676_CR40","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.ahj.2005.04.017","volume":"151","author":"BF Gage","year":"2006","unstructured":"Gage BF, Yan Y, Milligan PE, et al. Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J. 2006;151:713\u20139.","journal-title":"Am Heart J"}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-024-00676-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40256-024-00676-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-024-00676-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T16:30:28Z","timestamp":1730305828000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40256-024-00676-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["676"],"URL":"https:\/\/doi.org\/10.1007\/s40256-024-00676-y","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,6]]},"assertion":[{"value":"22 August 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No external funding was used in the preparation of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Francesco Angeli, Luca Bergamaschi, Matteo Armillotta, Angelo Sansonetti, Andrea Stefanizzi, Lisa Canton, Francesca Bodega, Nicole Suma, Sara Amicone, Damiano Fedele, Davide Bertolini, Andrea Impellizzeri, Francesco Pio Tattilo, Daniele Cavallo, Lorenzo Bartoli, Ornella Di Iuorio, Khrystyna Ryabenko, Marcello Casuso Alvarez, Virginia Marinelli, Claudio Asta, Mariachiara Ciarlantini, Giuseppe Pastore, Andrea Rinaldi, Daniela Paola Pomata, Ilaria Caldarera, and Carmine Pizzi declare they have no potential conflicts of interest that might be relevant to the contents of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"FA and LB contributed to the conception and design of this study. AR, LB, AS, MA, AS, SA, AI, NS, FB, DB, LC, DF, FPT, DC, KR, ODI, MC, MCA, CA, VM, GP and DPP organized the database and collected data. LB and FA performed the statistical analysis. FA and LB wrote the first draft of the manuscript. IC and CP wrote sections of the manuscript. CP revised the article and approved the final version of the manuscript. All authors contributed to manuscript revision, and read and approved the submitted version.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors' contributions"}},{"value":"CP is the guarantor of this research and as such had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of guarantor"}},{"value":"The datasets generated and\/or analyzed during the current study are available from the corresponding author on reasonable request.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability statement"}},{"value":"The study protocol received approval from the local Ethics Committee (Comitato Etico Indipendente dell\u2019Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi). Data were collected as part of an approved observational study. The present study was conducted according to the principles of the Declaration of Helsinki.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All patients were informed about their participation in the registry and provided informed consent for the anonymous publication of scientific data.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Not applicable.","order":10,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}